Related Experiment Video
Updated: May 23, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Morphine activates neuroinflammation in a manner parallel to endotoxin
Xiaohui Wang1, Lisa C Loram, Khara Ramos
1Department of Chemistry and Biochemistry, Center for Neuroscience, and Biofrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309, USA.
Abstract:
Opioids create a neuroinflammatory response within the CNS, compromising opioid-induced analgesia and contributing to various unwanted actions. How this occurs is unknown but has been assumed to be via classic opioid receptors. Herein, we provide direct evidence that morphine creates neuroinflammation via the activation of an innate immune receptor and not via classic opioid receptors. We demonstrate that morphine binds to an accessory protein of Toll-like receptor 4 (TLR4), myeloid differentiation protein 2 (MD-2), thereby inducing TLR4 oligomerization and triggering proinflammation. Small-molecule inhibitors, RNA interference, and genetic knockout validate the TLR4/MD-2 complex as a feasible target for beneficially modifying morphine actions. Disrupting TLR4/MD-2 protein-protein association potentiated morphine analgesia in vivo and abolished morphine-induced proinflammation in vitro, the latter demonstrating that morphine-induced proinflammation only depends on TLR4, despite the presence of opioid receptors. These results provide an exciting, nonconventional avenue to improving the clinical efficacy of opioids.
Insights
Morphine triggers neuroinflammation through Toll-like receptor 4 (TLR4) and myeloid differentiation protein 2 (MD-2), not opioid receptors. Targeting this complex enhances pain relief and reduces inflammation, improving opioid efficacy.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Opioids can cause neuroinflammation in the central nervous system (CNS), which reduces their pain-relieving effects and causes side effects.
- The mechanism behind opioid-induced neuroinflammation has been unclear, with the assumption that it involves traditional opioid receptors.
Purpose of the Study:
- To investigate the mechanism by which morphine induces neuroinflammation.
- To determine if opioid-induced neuroinflammation involves classic opioid receptors or other pathways.
- To explore the potential of targeting novel pathways to improve opioid therapy.
Main Methods:
- Morphine's interaction with Toll-like receptor 4 (TLR4) and its accessory protein myeloid differentiation protein 2 (MD-2) was examined.
- Small-molecule inhibitors, RNA interference, and genetic knockout models were used to validate the TLR4/MD-2 complex.
- The effect of disrupting the TLR4/MD-2 association on morphine analgesia and inflammation was assessed in vitro and in vivo.
Main Results:
- Morphine activates neuroinflammation by binding to MD-2, leading to TLR4 oligomerization and proinflammation, independent of classic opioid receptors.
- The TLR4/MD-2 complex was validated as a target for modulating morphine's effects.
- Inhibition of the TLR4/MD-2 complex enhanced morphine analgesia in vivo and prevented morphine-induced inflammation in vitro.
Conclusions:
- Morphine-induced neuroinflammation is mediated by the innate immune receptor TLR4/MD-2 complex, not by classic opioid receptors.
- Targeting the TLR4/MD-2 complex offers a novel strategy to improve the clinical effectiveness of opioids by enhancing analgesia and mitigating adverse inflammatory responses.
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Nociception
Acute Inflammation III: Local and Systemic Effects
